Brevan Howard Capital Management LP Exact Sciences Corp Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 22,895 shares of EXAS stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,895Holding current value
$1.35 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.05 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$934 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$845 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$711 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$394 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.4B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...